References
- Jansen J BMJ, Lamers C BHW. Medical treatment of reflux oesophagitis. J Drug Ther Res 1989; 14: 45–49
- Vantrappen G, Janssens J. Pathophysiology and treatment of gastro-oesophageal reflux disease. Scand J Gastroenterol 1989; 24: 7–12, suppl 165
- Stancin C, Bennet JR. Oesophageal acid clearing: one factor in the production of reflux oesophagitis. Gut 1974; 15: 852–857
- Helm J F. Esophageal acid clearance. J Clin Gastroenterol 1986; 8: 5–11, suppl 1
- McCallum R W, Berkowitz D M, Lerner E. Gastric emptying in patients with gastroesophageal reflux. Gastroenterology 1981; 80: 285–291
- Richter JE. A critical review of current medical therapy for gastroesophageal reflux disease. J Clin Gastroenterol 1984; 8: 72–80, suppl 1
- Wesdorp E, Bartelsman J, Pape K, Dekker W, Tijtgat GN. Oral cimetidine in reflux esophagitis: a double blind controlled trial. Gastroenterology 1978; 74: 811–814
- Behar J, Brand D L, Brown FC. Cimetidine in the treatment of symptomatic gastroesophageal reflux: a double blind controlled trial. Gastroenterology 1978; 74: 441–448
- Powell-Jackson P, Barkley H, Northfield TC. Effect of cimetidine in symptomatic gastroesophageal reflux. Lancet 1978; 1068–1070
- Fiasse R, Hanin C, Lepot A, Descamps C, Lamy F, Dive C. Controlled trial of cimetidine in reflux esophagitis. Dig Dis Sci 1980; 25: 750–755
- Brown P. Cimetidine in the treatment of reflux esophagitis. Med J Aust 1979; 2: 96–97
- Druguet M, Lambert R. Oral cimetidine in reflux esophagitis: a double blind controlled trial. Proceedings of the second national symposium., A Dress, F Barbier, C Harvengt, G Tijtgat. Exerpta Medica, Amsterdam 1980; 30–36
- Festen H PM, Driessen W MM, Lamers C BHW, Van Tongeren J HM. Treatment of reflux esophagitis with cimetidine. Ned J Med 1980; 23: 237–240
- Bennett J R, Buckton G, Martin MD. Cimetidine in gastroesophageal reflux. Digestion 1983; 25: 166–176
- Wesdorp J C, Dekker W, Klinkenberg-Knol EC. Treatment of reflux oesophagitis with ranitidine. Gut 1983; 24: 921–924
- Sherbanish R, Wensel R, Baily R. Ranitidine in the treatment of symptomatic gastroesophageal reflux disease. J Clin Gastroenterol 1984; 6: 9–15
- Hine K R, Homes G KT, Melikian V, Lucey M, Fairclough PD. Ranitidine in reflux esophagitis. Digestion 1984; 29: 119–123
- McCallum R W, Eskelman F, Nardi R. A double-blind multicenter trial to compare the efficacy of ranitidine and placebo in the short-term treatment of chronic gastroesophageal reflux disease. Gastroenterology 1984; 86: 1179
- Grove O, Bekker C, Jeppe-Hansen G. Ranitidine and high dose antacid in reflux esophagitis: a randomized placebo controlled trial. Scand J Gastroenterol 1985; 20: 457–461
- Koelz H R, Birckler R, Oveholz A, et al. Healing and relapse in reflux esophagitis during treatment with ranitidine. Gastroenterology 1986; 91: 1198–1206
- Klinkenberg-Knol E C, Jansen J BMJ, Festen H PM, Meuwissen S GM, Lamers C BHW. Double-blind multicenter comparison of omeprazole and ranitidine in the treatment of oesophagitis. Lancet 1987; 1: 349–351
- Hetzel D J, Dent J, Reed W D, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988; 95: 303–312
- Vantrappen G, Rutgeers L, Schurmans P, Coene-Grachts JL. Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis. Dig Dis Sci 1988; 33: 523–529
- Zeitoun P, de Desjars, Keranroue M, Isal JP. Omeprazole versus ranitidine in erosive oesophagitis. Lancet 1987; 2: 621–622
- Havelund T, Laursen L S, Skoubo-Kristensen E, et al. Omeprazole and ranitidine in treatment of reflux oesophagitis: double-blind comparative trial. Br Med J 1988; 296: 89–92
- Sandmark S, Carlsson R, Fausa S, Lundell L. Omeprazole or ranitidine in the treatment of reflux esophagitis. Scand J Gastroenterol 1988; 23: 625–632
- Dehn T C, Shephard H A, Collin-Jones D, Kettlewell MG. Double-blind comparative study of omeprazole (40 mg) vscimetidine (400 mgq.d.s.) in the treatment of erosive reflux oesophagitis. Gut 1988; A1440
- Jones D B, Howden C W, Burget D W, Kerr G D, Hunt RH. Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs. Gut 1987; 28: 1120–1127
- Howden C W, Hunt RH. The relationship between suppression of acidity and gastric ulcer healing rates. Aliment Pharmacol Ther 1990; 4: 25–33
- Ekman L, Hansson E, Havn N, Carlsson E, Lundberg C. Toxicological studies on omeprazole. Scand J Gastroenterol 1985; 20: 53–69, suppl 108
- Creutzfeldt W. The achlorhydria-carcinoid sequence: role of gastrin. Digestion 1988; 39: 61–79
- Brunner G, Creutzfeldt W, Harke U, Lamberts R. Therapy with omeprazole in patients with peptic ulcerations resistant to extended high-dose ranitidine treatment. Digestion 1988; 39: 80–90
- Jansen J BMJ, Klinkenberg-Knol E C, Meuwissen S GM, et al. Effect of long-term treatment with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux esophagitis. Gastroenterology 1990; 99: 621–628
- Johnson N J, Boyd E JS, Mills J G, Wood JR. Acute treatment of reflux oesophagitis: a multicentre trial to compare 150 mg ranitidine b.d. with 300 mg ranitidine q.d.s. Aliment Pharmacol Ther 1989; 3: 259–266
- Sekiguchi T, Takasu Y, Miwa T, et al. Clinical study of famotidine in reflux esophagitis. Med Consult New Remedies 1983; 20: 2467–2485